Carol Yepes/Moment via Getty Images The rising popularity of the GLP-1 class of anti-obesity medications developed by Novo Nordisk (NVO)…
Read More »GLP1s
Mohammed Haneefa Nizamudeen/iStock via Getty Images Piper Sandler said it expects upcoming results from a Novo Nordisk (NVO) study of…
Read More »CR European regulators reportedly plan to seek more information from drugmakers such as Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY)…
Read More »